Anti-Human CD13 [Clone 22A5] — CF®700
Anti-Human CD13 [Clone 22A5] — CF®700
Product No.: C1671CF
- -
- -
Antibody DetailsProduct DetailsReactive Species Human Host Species Mouse Immunogen Purified Recombinant Human CD13 (>98%) Product Concentration 0.2 mg/ml Formulation This CF®700 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative. State of Matter Liquid Storage and Handling This CF®700 conjugate is stable when stored at 2-8°C, protected from light. Do not freeze. Regulatory Status Research Use Only Country of Origin USA Shipping 2-8°C Wet Ice Excitation Laser 633, 635, 680, or 685 nm Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity Mouse Anti-Human CD13 (Clone 22A5) recognizes an epitope on Human CD13. This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype. Background Anti-Human CD13 can be used to study myeloid cell functions as well as to immunophenotype leukemias. CD13 is present on basophils from subjects with chronic myeloid leukemia (CML) and on granulocytes from subjects with systemic lupus erythematosus (SLE). Antigen Distribution The CD13 antigen is present on most cells of myeloid origin, including granulocytes and monocytes in normal peripheral blood. CD13 is not expressed on B-cells, T-cells, platelets or erythrocytes. Expression of this antigen is greater on monocytes than on granulocytes. Ligand/Receptor Coronavirus receptor PubMed NCBI Gene Bank ID UniProt.org Research Area Immunology . Stem Cell References & Citations1. Horton, A. M. et al. (1985) Cancer Res. 45:5663 Technical Protocols Certificate of Analysis |
Related Products
Formats Available
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
